Vaxzevria (previously COVID-19 Vaccine AstraZeneca) - direct healthcare professional communication (DHPC)

ChAdOx1-SARS-COV-2
DHPCHuman

Romanian is available via eTranslation, the European Commission's machine translation service.

Translate to Romanian | Important information about machine translation

Despre

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documente

Direct healthcare professional communication (DHPC): Vaxzevria/COVID-19 Vaccine AstraZeneca: Risk of thrombosis in combination with thrombocytopenia - Updated information

English (EN) (155.7 KB - PDF)

Prima publicare:
Vizualizare

Key facts

Medicine name
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
Active substance
ChAdOx1-SARS-COV-2
Therapeutic area (MeSH)
COVID-19 virus infection
Procedure number
EMEA/H/C/005675/II/0014
Regulatory outcome
Variation
DHPC type
Type II variation
Human ATC codes
J07BX03
Dissemination date

Share this page